These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36868262)

  • 21. Successful Use of Recombinant Human C1-INH in a Patient with Acquired Angioedema due to C1 Inhibitor Deficiency and an Unusually High Titer of Anti-C1-Inhibitor Autoantibodies.
    Jesenak M; Brndiarova M; Banovcin P; Varga L; Farkas H
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):255-256. PubMed ID: 32732186
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term prophylaxis with C1-inhibitor concentrate in patients with hereditary angioedema.
    Pedrosa M; Lobera T; Panizo C; Jurado J; Caballero T
    J Investig Allergol Clin Immunol; 2014; 24(4):271-3. PubMed ID: 25219111
    [No Abstract]   [Full Text] [Related]  

  • 23. New drugs to treat hereditary angioedema.
    Scheinfeld N
    Skinmed; 2013; 11(6):357-9. PubMed ID: 24517042
    [No Abstract]   [Full Text] [Related]  

  • 24. Hereditary cause of severe recurrent bowel swelling that requires targeted therapy.
    Fernando SL; Li J
    Med J Aust; 2014 Feb; 200(3):179. PubMed ID: 24528436
    [No Abstract]   [Full Text] [Related]  

  • 25. Catabolism of C1 inhibitor influences the response to replacement therapy in hereditary angioedema.
    Cicardi M; Zanichelli A; Suffritti C; Wu MA; Machnig T; De Silvestri A; Regazzi M; Tinelli C
    J Allergy Clin Immunol; 2017 Jun; 139(6):2005-2007.e1. PubMed ID: 28025012
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful C1 esterase inhibitor therapy in a child with a novel type 3 hereditary angioedema-like syndrome.
    Rasmussen JL; Park MA; Fischer PR
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):462-3. PubMed ID: 22626603
    [No Abstract]   [Full Text] [Related]  

  • 27. Three new drugs for hereditary angioedema.
    Med Lett Drugs Ther; 2010 Aug; 52(1345):66-7. PubMed ID: 20724964
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent advances in the management of hereditary angioedema.
    Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
    J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A roadmap for optimal care of the patient with hereditary angioedema.
    Castaldo AJ; Riedl MA; Settipane RA; Bellanti JA
    Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S01-S02. PubMed ID: 33109316
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcomes of long term treatments of type I hereditary angioedema in a Turkish family.
    Akoglu G; Kesim B; Yildiz G; Metin A
    An Bras Dermatol; 2017; 92(5):655-660. PubMed ID: 29166502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.
    Zuraw BL; Busse PJ; White M; Jacobs J; Lumry W; Baker J; Craig T; Grant JA; Hurewitz D; Bielory L; Cartwright WE; Koleilat M; Ryan W; Schaefer O; Manning M; Patel P; Bernstein JA; Friedman RA; Wilkinson R; Tanner D; Kohler G; Gunther G; Levy R; McClellan J; Redhead J; Guss D; Heyman E; Blumenstein BA; Kalfus I; Frank MM
    N Engl J Med; 2010 Aug; 363(6):513-22. PubMed ID: 20818886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients.
    Busse P; Baker J; Martinez-Saguer I; Bernstein JA; Craig T; Magerl M; Riedl M; Shapiro R; Frank M; Lumry W; Rosch J; Edelman J; Williams-Herman D; Feuersenger H; Rojavin M;
    J Allergy Clin Immunol Pract; 2017; 5(4):1142-1145. PubMed ID: 28286153
    [No Abstract]   [Full Text] [Related]  

  • 33. New Treatments for Hereditary Angioedema.
    Johnson NM; Phillips MA
    Skin Therapy Lett; 2018 Jan; 23(1):6-8. PubMed ID: 29357215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic agents for hereditary angioedema.
    Giavina-Bianchi P; Motta A; Kalil J
    N Engl J Med; 2011 Jan; 364(1):85; author reply 86. PubMed ID: 21208116
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy.
    Moldovan D; Bernstein JA; Hakl R; Porebski G; Poarch K; Lumry WR; Relan A
    J Allergy Clin Immunol Pract; 2019; 7(8):2938-2940. PubMed ID: 31170541
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of hereditary angioedema: When the goal is having a normal life.
    Arruda LK; Ferriani MPL
    J Allergy Clin Immunol; 2021 Jul; 148(1):80-82. PubMed ID: 34058236
    [No Abstract]   [Full Text] [Related]  

  • 37. Hereditary angioedema: a clinical review for the otolaryngologist.
    Anon JB
    Ear Nose Throat J; 2011 Jan; 90(1):32-9. PubMed ID: 21229509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of pdC1-INH concentrate for long-term prophylaxis during pregnancy in hereditary angioedema with normal C1-INH.
    Garcia JFB; Takejima P; Veronez CL; Aun MV; Motta AA; Kalil J; Pesquero JB; Giavina-Bianchi P
    J Allergy Clin Immunol Pract; 2018; 6(4):1406-1408. PubMed ID: 29439936
    [No Abstract]   [Full Text] [Related]  

  • 39. Real-life experience with long-term prophylactic C1 inhibitor concentrate treatment of patients with hereditary angioedema: Effectiveness and cost.
    Rasmussen ER; Aagaard L; Bygum A
    Ann Allergy Asthma Immunol; 2016 May; 116(5):476-7. PubMed ID: 27017563
    [No Abstract]   [Full Text] [Related]  

  • 40. Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks.
    Wasserman RL; Levy RJ; Bewtra AK; Hurewitz D; Craig TJ; Kiessling PC; Keinecke HO; Bernstein JA
    Ann Allergy Asthma Immunol; 2011 Jan; 106(1):62-8. PubMed ID: 21195947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.